SOD1 and amyotrophic lateral sclerosis: Chronic DR accelerated clinical onset and progression and shortened the lifespan while transiently improving motor performance in a mouse model of ALS expressing human SOD1 G93A mutant [137], possibly by increasing lipid peroxidation, inflammation, and apoptosis [138].